Metabolic conversion as a pre-receptor control mechanism for lipophilic hormones

European Journal of Biochemistry

Volumn 268, Issue 15, 2001, Pages 4113-4125

  Nobel, Stefan ^a,b   Abrahmsen, Lars ^a   Oppermann, Udo ^c  

^a BIOVITRUM AB   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

DHEA; Hormone metabolism; Hydroxysteroid dehydrogenase; Nuclear receptor; Retinoid; Short chain dehydrogenases reductases; Steroid; Thyroid hormone

Indexed keywords

ALCOHOL DEHYDROGENASE; ANDROGEN; ANDROSTENEDIONE; ARACHIDONIC ACID DERIVATIVE; CELL NUCLEUS RECEPTOR; CORTICOSTERONE; ENZYME; ESTRADIOL; ESTROGEN; ESTRONE; GESTAGEN; GLUCOCORTICOID; HORMONE PRECURSOR; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASE; ICOSANOID; LIGAND; LIOTHYRONINE; MINERALOCORTICOID; NEUROSTEROID; OXIDOREDUCTASE; OXYGENASE; PRASTERONE; PROSTAGLANDIN; RETINOIC ACID RECEPTOR; RETINOID; STEROID HORMONE; STEROID RECEPTOR; SULFOTRANSFERASE; TESTOSTERONE; THROMBOXANE; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROXINE; TRANSCRIPTION FACTOR; UNINDEXED DRUG;

BIOTRANSFORMATION; CELL SPECIFICITY; CHEMICAL STRUCTURE; ENZYME ACTIVITY; EVOLUTION; HORMONAL REGULATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HORMONE RESPONSIVE ELEMENT; HORMONE SYNTHESIS; HUMAN; METABOLIC ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL PROCESSING; TARGET CELL;

ANIMALS; GLUCOCORTICOIDS; HORMONES; HUMANS; LIGANDS; MINERALOCORTICOIDS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; STEROIDS;

EID: 0034836548     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2001.02359.x     Document Type: Review

References (142)

1. Steroid hormone receptors: Many actors in search of a plot
2. The nuclear receptor superfamily: The second decade
3. Nuclear receptor cofactors as chromatin remodelers
4. Orphan nuclear receptors: Shifting endocrinology into reverse
5. A unified nomenclature system for the nuclear receptor superfamily
6. Enhanced relaxation of porcine coronary arteries after acute exposure to a physiological level of 17β-estradiol involves non-genomic mechanisms and the cyclic AMP cascade
7. Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions
8. Coactivator and corepressor complexes in nuclear receptor function
9. Increasing the complexity of coactivation in nuclear receptor signaling
10. Nuclear receptor coregulators: Cellular and molecular biology
11. Coactivators and corepressors as mediators of nuclear receptor function: An update
12. A mechanistic basis for distinct mineralo-corticoid and glucocorticoid receptor transcriptional specificities
13. Retinoic acid receptors and retinoid X receptor-α down-regulate the transforming growth factor-β 1 promoter by antagonizing AP-1 activity
14. Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: Synergistic activation of IL-6 response element by IL-6 and glucocorticoid
15. Transcriptional cross-talk, the second mode of steroid hormone receptor action
16. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
17. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor
18. Glucocorticoid receptor phosphorylation: Overview, function and cell cycle-dependence
19. Cross-talk between peptide growth factor and estrogen receptor signaling pathways
20. Intracrinology
21. DHEA and peripheral androgen and estrogen formation: Intracrinology
22. Intracrinology: Role of the family of 17̈-hydroxysteroid dehydrogenases in human physiology and disease
23. Short-chain dehydrogenases/reductases (SDR)
24. Structure function relationships of hydroxysteroid dehydrogenases
25. Molecular endocrinology of hydroxysteroid dehydrogenases
26. Genetic disorders of steroid hormone synthesis and metabolism
27. Non-genomic mechanisms of action of steroid hormones
28. Paracrine glucocorticoid activity produced by mouse thymic epithelial cells
29. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation
30. Mutations in the NSDHL gene, encoding a 3̈-hydroxysteroid dehydrogenase, cause CHILD syndrome
31. Male pseudohermaphroditism caused by mutations of testicular 17 ̈-hydroxysteroid dehydrogenase 3
32. The ups and downs of glucocorticoid physiology. Permissive and suppressive effects revisited
33. Dual function of 11β-hydroxysteroid dehydrogenase in placenta: Modulating placental glucocorticoid passage and local steroid action
34. Biosynthesis and metabolism of adrenocorticol steroids
35. Assessment of mineralocorticoid activity in the rabbit colon
36. Primary structure and expression of a functional human glucocorticoid receptor cDNA
37. Cloning of human mineralocorticoid receptor complementary DNA: Tructural and functional kinship with the glucocorticoid receptor
38. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol
39. Human hypertension caused by mutations in the kidney isozyme of 11 β-hydroxysteroid dehydrogenase
40. Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2
41. Aldosterone and mineralocorticoid receptors: Orphan questions
42. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic- pituitary-adrenal axis activity
43. 11β-hydroxysteroid dehydrogenase
44. 11 β-hydroxysteroid dehydrogenase is an exclusive 11 β-reductase in primary cultures of rat hepatocytes: Effect of physicochemical and hormonal manipulations
45. Tissue localization of 11β-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor
46. 11β-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress
47. Determination of prednisone and prednisolone in human serum by high-performance liquid chromatography - Especially on impaired conversion of corticosteroids in patients with chronic liver disease
48. Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis
49. Clinical case seminar. Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11β-hydroxysteroid dehydrogenase reductase activity
50. Apparent cortisone reductase deficiency: A functional defect in 11β-hydroxysteroid dehydrogenase type 1
51. Glucocorticoids and insulin resistance: Old hormones, new targets
52. Type 1 11β-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets
53. DHEA deficiency syndrome: A new term for old age?
54. Steroid sulfotransferases
55. The metabolic clearance rates of dehydroepiandrosterone, testosterone and their sulfate esters in man, rat and rabbit
56. Pharmacogenetics of sulfotransferase
57. The role of cytokines and sulfatase inhibitors in regulating oestrogen synthesis in breast tumours
58. The sulfatase gene family
59. Corticosterone storage within the adrenal cortex: Evidence for a sulfate conjugate
60. 17β-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; Nomenclature and main characteristics of the 17HSD/KSR enzymes
61. 3β-hydroxysteroid dehydrogenase/delta5→4-isomerase activity associated with the human 17β-hydroxysteroid dehydrogenase type 2 isoform
62. Evolution of mammalian 11β- and 17β-hydroxysteroid dehydrogenases-type 2 and retinol dehydrogenases from ancestors in Caenorhabitis elegans and evidence for horizontal transfer of a eukaryote dehydrogenase to E. coli
63. Expression of mouse 17β-hydroxysterid dehydrogenase/17-ketosterid reductase type 7 in the ovary, uterus, and placenta: Localization from implantation to late pregnancy
64. Loss of estrogen inactivation in colonic cancer
65. Design and synthesis of new steroidal inhibitors of estrogen synthase (aromatase)
66. Potent inhibition of estrogen sulfotrasferase by hydroxylated PCB metabolites: A novel pathway explaining the estrogenic activity of PCBs
67. Effects of ethanol on steroid profiles in the rat testis
68. Effects of ethanol on the levels of unconjugated and conjugated androgens and estrogens in plasma of men
69. Redox effects of ethanol on steroid metabolism
70. Deletion of steroid 5 α-reductase 2 gene in male pseudohermaphroditism
71. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: Functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones
72. Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle
73. Function of human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase in androgen metabolism
74. Identification and quantitative determination of steroids in bovine corpus luteum during oestrous cycle and pregnancy
75. Sulfates of pregnanolones, pregnanediols and 16-hydroxysteroids in plasma from pregnant women
76. Characterization of a human 20α-hydroxysteroid dehydrogenase
77. Identification of a major prolactin-regulated protein as 20 α-hydroxysteroid dehydrogenase: Coordinate regulation of its activity, protein content, and messenger ribonucleic acid expression
78. Enzyme-mediated protection of the mineralocorticoid receptor against progesterone in the human kidney
79. A new nomenclature for the aldo-keto reductase superfamily
80. Molecular cloning and characterization of the rat ovarian 20 α-hydroxysteroid dehydrogenase gene
81. Neurosteroids: Expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system
82. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain
83. A receptor
84. A receptor a4 subunit suppression prevents withdrawal properties of an endogenous steroid
85. Neuroactive steroids
86. Inhibition of oxytocin receptor function by direct binding of progesterone
87. New' active steroids and an unforeseen mechanism of action
88. Vitamin D
89. Cytochrome P450 enzymes in the bio-activation of vitamin D to its hormonal form
90. 1-Alpha,25-dihydroxy vitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation
91. 1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck
92. Genetic control of bone density and turnover: Role of the collagen 1α1, estrogen receptor, and vitamin D receptor genes
93. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance
94. Glucocorticoids and immune function: Unknown dimensions and new frontiers
95. Glucocorticoids and immune function: Physiological relevance and pathogenic potential of hormonal dysfunction
96. A decade of molecular biology of retinoic acid receptors
97. Retinoid-binding proteins: Mediators of retinoid action
98. Interactions of retinoid binding proteins and enzymes in retinoid metabolism
99. Three independent lines of evidence suggest retinoids as causal to schizophrenia
100. A gene knockout corroborates the integral function of cellular retinol-binding protein in retinoid metabolism
101. Molecular basis for differential substrate specificity in class IV alcohol dehydrogenases: A conserved function in retinoid metabolism but not in ethanol oxidation
102. Families of retinoid dehydrogenases regulating vitamin A function: Production of visual pigment and retinoic acid
103. Cellular retinol-binding protein I is essential for vitamin A homeostasis
104. Impaired retinol utilization in Adh4 alcohol dehydrogenase mutant mice
105. Metabolic deficiencies in alcohol dehydrogenase Adh1, Adh3, and Adh4 null mutant mice. Overlapping roles of Adh1 and Adh4 in ethanol clearance and metabolism of retinol to retinoic acid
106. Cloning of a cDNA for liver microsomal retinol dehydrogenase. A tissue-specific, short-chain alcohol dehydrogenase
107. Expression cloning and characterization of oxidative 17β- and 3α-hydroxysteroid dehydrogenases from rat and human prostate
108. +-dependent dehydrogenase that oxidizes all-trans-retinol and 3α-hydroxysteroids
109. Complementary deoxyribonucleic acid cloning and enzymatic characterization of a novel 17β/3α-hydroxysteroid/retinoid short chain dehydrogenase/reductase
110. Relationships within the aldehyde dehydrogenase extended family
111. Peripheral metabolism of thyroid hormones: A review
112. Crucial role for type II iodothyronine deiodinase in the metabolic coupling between glial cells and neurons during brain development
113. Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues
114. Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase
115. Type 3 lodothyronine deiodinase: Cloning, in vitro expression, and functional analysis of the placental selenoenzyme
116. Expression profiles of the three iodothyronine deiodinases D1, D2, and D3 in the developing rat
117. Development effects of thyroid hormone: The role of deiodinases in regulatory control
118. Lipid mediator networks in cell signaling: Update and impact of cytokines
119. Structure, function, and regulation of leukotriene A4 hydrolase
120. Purification and structural characterization of placental NAD(+)-linked-hydroxyprostaglandin dehydrogenase. The primary structure reveals the enzyme to belong to the short-chain alcohol dehydrogenase family
121. Cloning and sequence analysis of the cDNA for human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase
122. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9α, 11β-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels
123. Origins and evolutionary diversification of the nuclear receptor superfamily
124. Evolution of the P450 gene superfamily: Animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation
125. Eighth Adolf Butenandt lecture. Why are so many hormones steroids?
126. Cholesterol in signal transduction
127. Comparative anatomy of the aldo-keto reductase superfamily
128. A common ancestor for human placental 17 β-hydroxysteroid dehydrogenase, Streptomyces coelicolor actIII protein, and Drosophila melanogaster alcohol dehydrogenase
129. Evolution of regulation of steroid-mediated intercellular communication in vertebrates: Insights from flavonoids, signals that mediate plant-rhizobia symbiosis
130. Steroid receptor phylogeny and vertebrate origins
131. Roles of PPARs in health and disease
132. PPAR-gamma agonists: Therapeutic role in diabetes, inflammation and cancer
133. The SEEM: Selective estrogen enzyme modulators in breast cancer
134. Hormonal carcinogenesis
135. Steroid dehydrogenase structures, mechanism of action, and disease
136. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism
137. Don't know much bile-ology
138. Oxysterol biosynthetic enzymes
139. The LXRs: A new class of oxysterol receptors
140. Multiple mechanisms for polyunsaturated fatty acid regulation of hepatic gene transcription
141. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain
142. A systematic analytical chemistry/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts: Characterization of peroxisome proliferator-activated receptor activators in plasma